{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T00:11:44Z","timestamp":1780791104770,"version":"3.54.1"},"reference-count":13,"publisher":"SAGE Publications","issue":"7","license":[{"start":{"date-parts":[[2025,3,23]],"date-time":"2025-03-23T00:00:00Z","timestamp":1742688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Int J STD AIDS"],"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:p>The dyslipidemia in people living with HIV differs from the general population because combination antiretroviral therapy may not only induce dyslipidemia but also interact with lipid-lowering agents.<\/jats:p>\n                  <jats:p>Monoclonal antibodies that target proprotein convertase subtilisin\/kexin type 9 (PCSK9) have recently been demonstrated to dramatically reduce LDL-C level (&gt;60%) in the majority of cases, and another interesting new option is inclisiran, a first-in-class, cholesterol-lowering small interfering RNA (siRNA) targeting PCSK9 mRNA and conjugated to triantennary N-acetylgalactosamine carbohydrates (GalNAc).<\/jats:p>\n                  <jats:p>We present the clinical case of a 62-year-old man living with HIV and dyslipidemia in whom new hypolipidemic drugs were fundamental in achieving adequate LDL values to prevent cardiovascular events.<\/jats:p>","DOI":"10.1177\/09564624251327237","type":"journal-article","created":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T00:42:25Z","timestamp":1742776945000},"page":"591-594","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":1,"title":["\u201cAre new lipid lowering agents a good option for achieving lipid goals in people living with HIV? A case report\u201d"],"prefix":"10.1177","volume":"36","author":[{"given":"Raffaele","family":"Ferri","sequence":"first","affiliation":[{"name":"Clinic of Infectious Diseases, Department of Medicine and Science of Aging, University \u201cG. D\u2019Annunzio\u201d, Chieti, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8795-5410","authenticated-orcid":false,"given":"Katia","family":"Falasca","sequence":"additional","affiliation":[{"name":"Clinic of Infectious Diseases, Department of Medicine and Science of Aging, University \u201cG. D\u2019Annunzio\u201d, Chieti, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacopo","family":"Vecchiet","sequence":"additional","affiliation":[{"name":"Clinic of Infectious Diseases, Department of Medicine and Science of Aging, University \u201cG. D\u2019Annunzio\u201d, Chieti, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Ucciferri","sequence":"additional","affiliation":[{"name":"Clinic of Infectious Diseases, Department of Medicine and Science of Aging, University \u201cG. D\u2019Annunzio\u201d, Chieti, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,3,23]]},"reference":[{"key":"e_1_3_5_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/hiv.13542"},{"issue":"4","key":"e_1_3_5_3_2","first-page":"198","article-title":"Hypertension in HIV: management and treatment","volume":"19","author":"Ucciferri C","year":"2017","unstructured":"Ucciferri C, Falasca K, Vecchiet J. Hypertension in HIV: management and treatment. AIDS Rev 2017; 19(4): 198\u2013211.","journal-title":"AIDS Rev"},{"key":"e_1_3_5_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(18)30043-2"},{"key":"e_1_3_5_5_2","doi-asserted-by":"publisher","DOI":"10.1097\/CM9.0000000000002879"},{"key":"e_1_3_5_6_2","doi-asserted-by":"publisher","DOI":"10.1258\/ijsa.2008.008419"},{"key":"e_1_3_5_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.26598"},{"key":"e_1_3_5_8_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2304146"},{"key":"e_1_3_5_9_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003121"},{"key":"e_1_3_5_10_2","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2022.2059559"},{"key":"e_1_3_5_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacl.2021.07.002"},{"key":"e_1_3_5_12_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02532964"},{"key":"e_1_3_5_13_2","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.M030528"},{"key":"e_1_3_5_14_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40256-023-00568-7"}],"container-title":["International Journal of STD &amp; AIDS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/09564624251327237","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/09564624251327237","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/09564624251327237","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T22:46:30Z","timestamp":1777675590000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/09564624251327237"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,23]]},"references-count":13,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["10.1177\/09564624251327237"],"URL":"https:\/\/doi.org\/10.1177\/09564624251327237","relation":{},"ISSN":["0956-4624","1758-1052"],"issn-type":[{"value":"0956-4624","type":"print"},{"value":"1758-1052","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,23]]}}}